Company Filing History:
Years Active: 2022
Title: Innovations of Sheng-Tai Tzeng in Cancer Detection
Introduction
Sheng-Tai Tzeng is a notable inventor based in New Taipei, Taiwan. He has made significant contributions to the field of cancer detection through his innovative patent. His work focuses on developing advanced probe combinations that enhance the accuracy of cancer diagnostics.
Latest Patents
Sheng-Tai Tzeng holds a patent for a "Probe combination for detection of cancer." This invention includes one or more sets of partial hepatitis B virus (HBV) targeting probes. When the sequences of each set of probes are aligned, they match a reference sequence of a genome of an HBV genotype or a direct repeat (DR) region on the genome. The design of the probes allows for overlapping sequences, which increases the reliability of the detection process. Additionally, the probe combination targets cancer hotspot genes such as CTNNB1, TERT, and TP53, as well as endogenous genes like GAPDH and GdX.
Career Highlights
Sheng-Tai Tzeng is associated with TCM Biotech International Corp., where he applies his expertise in biotechnology and cancer research. His innovative approach to probe design has the potential to significantly impact cancer diagnostics and treatment.
Collaborations
Sheng-Tai Tzeng collaborates with talented individuals in his field, including You-Yu Lin and Ya-Chun Wang. Their combined efforts contribute to advancing research and development in cancer detection technologies.
Conclusion
Sheng-Tai Tzeng's work exemplifies the importance of innovation in the medical field, particularly in cancer detection. His patented technology represents a significant step forward in improving diagnostic accuracy and patient outcomes.